SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-291800
Filing Date
2023-12-08
Accepted
2023-12-08 17:16:58
Documents
14
Period of Report
2023-12-08
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d626117d8k.htm   iXBRL 8-K 24836
2 EX-99.1 d626117dex991.htm EX-99.1 32868
6 GRAPHIC g626117g1209021354738.jpg GRAPHIC 3750
  Complete submission text file 0001193125-23-291800.txt   197359

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA aclx-20231208.xsd EX-101.SCH 2838
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE aclx-20231208_lab.xml EX-101.LAB 18737
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aclx-20231208_pre.xml EX-101.PRE 11699
8 EXTRACTED XBRL INSTANCE DOCUMENT d626117d8k_htm.xml XML 3465
Mailing Address 25 WEST WATKINS MILL ROAD SUITE A GAITHERSBURG MD 20878
Business Address 25 WEST WATKINS MILL ROAD SUITE A GAITHERSBURG MD 20878 240-723-6641
Arcellx, Inc. (Filer) CIK: 0001786205 (see all company filings)

IRS No.: 472855917 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41259 | Film No.: 231476336
SIC: 2836 Biological Products, (No Diagnostic Substances)